Genetic Variants, Immune Function, and Risk of Pre-Eclampsia among American Indians

American Journal of Reproductive Immunology

Volumn 67, Issue 2, 2012, Pages 152-159

  Best, Lyle G ^a   Nadeau, Melanie ^a   Davis, Kylie ^a   Lamb, Felicia ^a   Bercier, Shellee ^a   Anderson, Cindy M ^b  

^a Turtle Mountain Community College   (United States)

^b UNIVERSITY OF NORTH DAKOTA   (United States)

Author keywords

American Indian; Genetics; Immune function; Pre eclampsia

Indexed keywords

C REACTIVE PROTEIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 1ALPHA; MANNOSE BINDING LECTIN 2;

AGE; AMERICAN INDIAN; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; IMMUNITY; NULLIPARA; OBESITY; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; INDIANS, NORTH AMERICAN; POLYMORPHISM, SINGLE NUCLEOTIDE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; YOUNG ADULT;

EID: 84855350994     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2011.01076.x     Document Type: Article

References (48)

1. Young BC, Levine RJ, Karumanchi SA: Pathogenesis of preeclampsia. Annu Rev Pathol 2010; 5:173-192.
2. Lindheimer MD, Taler SJ, Cunningham FG: Hypertension in pregnancy. J Am Soc Hypertens 2010; 4:68-78.
3. Baumwell S, Karumanchi SA: Pre-eclampsia: clinical manifestations and molecular mechanisms. Nephron Clin Pract 2007; 106:c72-c81.
4. Maynard S, Epstein FH, Karumanchi SA: Preeclampsia and angiogenic imbalance. Annu Rev Med 2008; 59:61-78.
5. Bezerra PC, Leão MD, Queiroz JW, Melo EM, Pereira FV, Nóbrega MH, Jeronimo AK, Ferreira LC, Jerônimo SM, de Araújo AC: Family history of hypertension as an important risk factor for the development of severe preeclampsia. Acta Obstet Gynecol Scand 2010; 89:612-617.
6. Rigó Jr J, Boze T, Derzsy Z, Derzbach L, Treszl A, Lázár L, Sobel G, Vásárhelyi B: Family history of early-onset cardiovascular disorders is associated with a higher risk of severe preeclampsia. Eur J Obstet Gynecol Reprod Biol 2006:128:148-151.
7. Carr DB, Epplein M, Johnson CO, Easterling TR, Critchlow CW: A sister's risk: family history as a predictor of preeclampsia. Am J Obstet Gynecol 2005;193(3 Pt 2): 965-972.
8. Carty DM, Delles C, Dominiczak AF: Preeclampsia and future maternal health. J Hypertens 2010; 28:1349-1355.
9. Vatten LJ, Romundstad PR, Holmen TL, Hsieh CC, Trichopoulos D, Stuver SO: Intrauterine exposure to preeclampsia and adolescent blood pressure, body size, and age at menarche in female offspring. Obstet Gynecol 2003; 101:529-533.
10. Ferreira I, Peeters LL, Stehouwer CDA: Preeclampsia and increased blood pressure in the offspring: meta-analysis and critical review of the evidence. J Hypertens 2009; 27:1955-1959.
11. Arngrimsson R, Bjornsson S, Geirsson RT, Bjornsson H, Walker JJ, Snaedal G: Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population. Br J Obstet Gynaecol 1990; 97:762-769.
12. Lin J, August P: Genetic thrombophilias and preeclampsia: a meta-analysis. Obstet Gynecol 2005; 105:182-192.
13. Medica I, Kastrin A, Peterlin B: Genetic polymorphisms in vasoactive genes and preeclampsia: a meta-analysis. Eur J Obstet Gynecol Reprod Biol 2007; 131:115-126.
14. Best LG, Nadeau M, Bercier S, Dauphinais S, Davis J, Davis K, Poitra S, Anderson CM: Genetic variants, endothelial function, and risk of preeclampsia among American Indians. Hypertens Pregnancy 2010; [Epub ahead of print].
15. Best LG, Dorsam ST, Nadeau M, Burd L, Anderson CM: Genetic thrombophilia variants and risk for preeclampsia among American Indians. Hypertens Pregnancy 2009; 28:85-94.
16. GOPEC Consortium: Disentangling fetal and maternal susceptibility for pre-eclampsia: a British multicenter candidate-gene study. Am J Hum Genet 2005; 77:127-131.
17. Founds SA, Conley YP, Lyons-Weiler JF, Jeyabalan A, Hogge WA, Conrad KP: Altered global gene expression in first trimester placentas of women destined to develop preeclampsia. Placenta 2009; 30:15-24.
18. Molvarec A, Jermendy A, Kovacs M, Prohaszka Z, Rigo Jr J: Toll-like receptor 4 gene polymorphisms and preeclampsia: lack of association in a caucasian population. Hypertens Res 2008; 31:859-864.
19. Yie SM, Li LH, Xiao R, Librach CL: A single base-pair mutation in the 3′-untranslated region of HLA-G mRNA is associated with pre-eclampsia. Mol Hum Reprod 2008; 14:649-653.
20. Iversen AC, Nguyen OT, Tømmerdal LF, Eide IP, Landsem VM, Acar N, Myhre R, Klungland H, Austgulen R: The HLA-G 14bp gene polymorphism and decidual HLA-G 14bp gene expression in pre-eclamptic and normal pregnancies. J Reprod Immunol 2008; 78:158-165.
21. Vianna P, Dalmaz CA, Veit TD, Tedoldi C, Roisenberg I, Chies JA: Immunogenetics of pregnancy: role of a 14-bp deletion in the maternal HLA-G gene in primiparous pre-eclamptic brazilian women. Hum Immunol 2007; 68:668-674.
22. de Lima TH, Sass N, Mattar R, Moron AF, Torloni MR, Franchim CS, Daher S: Cytokine gene polymorphisms in preeclampsia and eclampsia. Hypertens Res 2009; 32:565-569.
23. Johnson MP, Roten LT, Dyer TD, East CE, Forsmo S, Blangero J, Brennecke SP, Austgulen R, Moses EK: The ERAP2 gene is associated with preeclampsia in Australian and Norwegian populations. Hum Genet 2009; 126:655-666.
24. Roberts JM, Pearson G, Cutler J, Lindheimer M, NHLBI Working Group on Research on Hypertension During Pregnancy: Summary of the NHLBI working group on research on hypertension during pregnancy. Hypertension 2003; 41:437-445.
25. International HapMap project [Internet], accessed, 8 April 2011 Available from
26. ACOG Committee on Obstetric Practice: ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002; 77:67-75.
27. Zacho J, Tybjaerg-Hansen A, Jensen JS, Grande P, Sillesen H, Nordestgaard BG: Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med 2008; 359:1897-1908.
28. Zee RY, Germer S, Thomas A, Raji A, Rhees B, Ridker PM, Lindpaintner K, Williams GH, Nathan DM, Martin M: C-reactive protein gene variation and type 2 diabetes mellitus: a case-control study. Atherosclerosis 2008; 197:931-936.
29. Miller DT, Zee RY, Suk Danik J, Kozlowski P, Chasman DI, Lazarus R, Cook NR, Ridker PM, Kwiatkowski DJ: Association of common CRP gene variants with CRP levels and cardiovascular events. Ann Hum Genet 2005;69(Pt 6):623-638.
30. Goddard KA, Tromp G, Romero R, Olson JM, Lu Q, Xu Z, Parimi N, Nien JK, Gomez R, Behnke E, Solari M, Espinoza J, Santolaya J, Chaiworapongsa T, Lenk GM, Volkenant K, Anant MK, Salisbury BA, Carr J, Lee MS, Vovis GF, Kuivaniemi H: Candidate-gene association study of mothers with pre-eclampsia, and their infants, analyzing 775 SNPs in 190 genes. Hum Hered 2007; 63:1-16.
31. Chappell S, Morgan L: Searching for genetic clues to the causes of pre-eclampsia. Clin Sci (Lond) 2006; 110:443-458.
32. Arngrímsson R, Hayward C, Nadaud S, Baldursdóttir A, Walker JJ, Liston WA, Bjarnadóttir RI, Brock DJ, Geirsson RT, Connor JM, Soubrier F: Evidence for a familial pregnancy-induced hypertension locus in the eNOS-gene region. Am J Hum Genet 1997; 61:354-362.
33. Skjaerven R, Vatten LJ, Wilcox AJ, Ronning T, Irgens LM, Lie RT: Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort. BMJ 2005; 331:877.
34. C Reactive Protein Coronary Heart Disease Genetics Collaboration (CCGC): Association between C reactive protein and coronary heart disease: Mendelian randomisation analysis based on individual participant data. BMJ 2011; 342:d548.
35. Lawlor DA, Harbord RM, Timpson NJ, Lowe GD, Rumley A, Gaunt TR, Baker I, Yarnell JW, Kivimäki M, Kumari M, Norman PE, Jamrozik K, Hankey GJ, Almeida OP, Flicker L, Warrington N, Marmot MG, Ben-Shlomo Y, Palmer LJ, Day IN, Ebrahim S, Smith GD: The association of C-reactive protein and CRP genotype with coronary heart disease: findings from five studies with 4, 610 cases amongst 18, 637 participants. PLoS ONE 2008; 3:e3011.
36. Kardys I, de Maat MP, Klaver CC, Despriet DD, Uitterlinden AG, Hofman A, de Jong PT, Witteman JC: Usefulness of combining complement factor H and C-reactive protein genetic profiles for predicting myocardial infarction (from the rotterdam study). Am J Cardiol 2007; 100:646-648.
37. Kuhlenbaeumer G, Huge A, Berger K, Kessler C, Voelzke H, Funke H, Stoegbauer F, Stoll M, Ringelstein EB: Genetic variants in the C-reactive protein gene are associated with microangiopathic ischemic stroke. Cerebrovasc Dis 2010; 30:476-482.
38. Morita A, Nakayama T, Soma M: Association study between C-reactive protein genes and ischemic stroke in japanese subjects. Am J Hypertens 2006; 19:593-600.
39. Komurcu-Bayrak E, Erginel-Unaltuna N, Onat A, Ozsait B, Eklund C, Hurme M, Mononen N, Laaksonen R, Hergenc G, Lehtimäki T: Association of C-reactive protein (CRP) gene allelic variants with serum CRP levels and hypertension in turkish adults. Atherosclerosis 2009; 206:474-479.
40. Kivimäki M, Lawlor DA, Smith GD, Kumari M, Donald A, Britton A, Casas JP, Shah T, Brunner E, Timpson NJ, Halcox JP, Miller MA, Humphries SE, Deanfield J, Marmot MG, Hingorani AD: Does high C-reactive protein concentration increase atherosclerosis? The Whitehall II Study. PLoS ONE 2008; 3:e3013.
41. Schumacher W, Cockcroft J, Timpson NJ, McEniery CM, Gallacher J, Rumley A, Lowe G, Smith GD, Wilkinson IB, Ben-Shlomo Y: Association between C-reactive protein genotype, circulating levels, and aortic pulse wave velocity. Hypertension 2009; 53:150-157.
42. Morita A, Nakayama T, Doba N, Hinohara S, Soma M: Polymorphism of the C-reactive protein (CRP) gene is related to serum CRP level and arterial pulse wave velocity in healthy elderly japanese. Hypertens Res 2006; 29:323-331.
43. Celik N, Ozan H: Maternal serum mannose-binding lectin in severe preeclampsia. Clin Exp Obstet Gynecol 2008; 35:179-182.
44. Than NG, Romero R, Erez O, Kusanovic JP, Tarca AL, Edwin SS, Kim JS, Hassan SS, Espinoza J, Mittal P, Mazaki-Tovi S, Friel L, Gotsch F, Vaisbuch E, Camacho N, Papp Z: A role for mannose-binding lectin, a component of the innate immune system in pre-eclampsia. Am J Reprod Immunol 2008; 60:333-345.
45. Vianna P, Da Silva GK, Dos Santos BP, Bauer ME, Dalmáz CA, Bandinelli E, Chies JA: Association between mannose-binding lectin gene polymorphisms and pre-eclampsia in brazilian women. Am J Reprod Immunol 2010; 64:359-374.
46. van de Geijn FE, Dolhain RJ, van Rijs W, Hazes JM, de Groot CJ: Mannose-binding lectin genotypes and pre-eclampsia: a case-control study. Hum Immunol 2007; 68:888-893.
47. Pendeloski KP, Sass N, Torloni MR, Mattar R, Moron AF, Franchim CS, Daher S: Immunoregulatory gene polymorphisms in women with preeclampsia. Hypertens Res 2011; 34:384-388.
48. Jääskeläinen E, Toivonen S, Keski-Nisula L, Paattiniemi EL, Helisalmi S, Punnonen K, Heinonen S: CTLA-4 polymorphism 49A-G is associated with placental abruption and preeclampsia in finnish women. Clin Chem Lab Med 2008; 46:169-173.